Skip to content

Profound Medical PROF Net Investment in Lease

Net Investment in Lease at other companies

TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
Bioventus logo
BioventusBVS
Globus Medical logo
Globus MedicalGMED

Segments

By geography

See full
CA$2.9M+747%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's net investment in lease?
Profound Medical (PROF) reported net investment in lease of $2.9M in Q1 2026.
How has Profound Medical's net investment in lease changed year-over-year?
Profound Medical's net investment in lease increased by 747.1% year-over-year, from $342K to $2.9M.
What is the long-term trend for Profound Medical's net investment in lease?
Over 2 years (2023 to 2025), Profound Medical's net investment in lease has grown at a -47.2% compound annual growth rate (CAGR), from $661K to $184K.